Providers/Grant Support
This activity is supported by an independent education grant from Lilly.
Credits Available
This activity does not offer credit.
Target Audience
This activity is designed to meet the educational needs of Imaging physicians, including Nuclear Medicine Physicians, Radiologists, Neuroradiologists, Radiology Physician Assistants, Imaging Residents. It is also suitable for Neurologists.
Program Overview
As the landscape of Alzheimer’s disease continues to evolve, PET imaging is playing an increasingly critical role in early and accurate diagnosis, disease staging, and treatment decision-making. But how can nuclear medicine and radiology physicians effectively integrate PET imaging into clinical practice while navigating regional variations, emerging tracers, and evolving guidelines?
This activity will cover the latest insights, practical strategies, and real-world case studies on PET imaging in Alzheimer’s disease. Featuring leading experts from Europe, Asia, and the USA, this program will provide a global perspective on best practices, challenges, and decision-making tools to optimize patient care.
Put your decision-making and interpretation skills into practice in a simulated environment. Presented with different patient characteristics, you will be challenged to choose the optimal tracer, accurately interpret the results, and advise on next steps.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Integrate best practice for the selection, interpretation, and reporting of PET biomarkers in the context of your local clinical practice
- Incorporate optimal communication and reporting methods to enhance interdisciplinary working and patient relationships
Faculty
Prof Hiroshi Matsuda
Director, Clinical Imaging Center for Healthcare
Nippon Medical School, Bunkyo City, Tokyo, Japan
Hiroshi Matsuda is Director of Drug discovery Research and Cyclotron Center, Southern TOHOKU Research Institute for Neuroscience from 2020 to 2025, and was Professor of Department of Biofunctional Imaging, Fukushima Medical University from 2021 to 2025. He has been Director of Clinical trials/Clinical research promotion office, Nippon Medical School, Clinical Imaging Center for Healthcare since April 2025.
Prof Matsuda is Visiting Professor of Saitama Medical University, and Board certified specialist of Japanese Society of Radiology, Japanese Society of Nuclear Medicine, and Japanese Society of Dementia Research.
He has been author of 417 English articles, 106 books (Japanese and English, editor 11), with an h-index 78.
Disclosures of Conflicts of Interest
Prof Hiroshi Matsuda
Disclosures
Grants-in-Aid for Scientific Research: Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry. Received Honoraria from PDRadiopharma.
Instructions for Participation
There are no fees for participating in this enduring activity. Read the information and faculty disclosures, participate in this online activity, and submit the evaluation form.
Disclosure of Unlabeled Use
Faculty participating in any CME activity are required to disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For questions please contact ime@springer.com